Pizzie Nick

Average Profitability
84.72%
Insider Buys Quantity
6
Insider Buys Sum
$447,323.91
Insider Sells Quantity
2
Insider Sells Sum
$1.95M

Insider Activity of Pizzie Nick

According to the SEC Form 4 filings, Pizzie Nick, being in a position of

  1. Chief Financial Officer at Axsome Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 15000 shares for $1.95M,
    over all time since 2018-06-19, has bought 78632 shares for $447,324, and sold 15000 shares for $1.95M.

The largest purchase of all time was on 2018-06-19 and amounted to 62000 shares of Axsome Therapeutics, Inc. for $192,160.

The largest sale of all time was on 2025-02-13 and amounted to 12000 shares of Axsome Therapeutics, Inc. for $1.56M.

Biography of Pizzie Nick

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,951,5302100

Comparison of Insiders on Amount of Buys and Sells

2025-02-14SaleAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
3,000
0.0062%
$131.07$393,210-4.14%
2025-02-13SaleAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
12,000
0.0244%
$129.86$1.56M-4.5%
2021-11-18PurchaseAxsome Therapeutics, Inc.
AXSM
CHIEF FINANCIAL OFFICER
955
0.0025%
$35.26$33,676+4.03%
2020-06-29PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
777
0.0021%
$76.64$59,549-5.1%
2019-09-26PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
2,180
0.0063%
$24.80$54,064+210.19%
2019-06-11PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
1,920
0.0057%
$20.80$39,936+117.89%
2019-03-19PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
10,800
0.0159%
$6.29$67,939+96.6%
2018-06-19PurchaseAxsome Therapeutics, Inc.
AXSM
Chief Financial Officer
62,000
0.2484%
$3.10$192,160+30.33%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD